Patent ID: 8501171

Claim:
A method for treating a cancer or an infection by a pathogenic agent, comprising: administering a composition of antibodies to a patient in need thereof, wherein said antibodies are specific to an antigen expressed by the cancer or infection to be treated in the patient, wherein the cancer or infection has a number of antigenic sites below 250,000 per target cell, and wherein said antibodies are over 60%, for the forms G0+G1+G0F+G1F, given that the forms G0F+G1F are lower than 50%, and wherein said antibodies are selected from the group consisting of anti-HLA-DR, anti-CD20, anti Ep-CAM, anti HER2, anti CD52, anti HER1, anti GD3, anti CA125, anti GD, anti GD2, anti CD-23 and anti Protein C, anti-KIR3DL2, anti-EGFR, anti-CD25, anti-CD38, anti-CD30, anti-CD33, and anti-CD44.